These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 556794)

  • 41. Studies of tryptamine and lysergic acid diethylamide (LSD) on cutaneous C-fiber and polysynaptic reflexes in the cat.
    Bell JA; Martin WR
    J Pharmacol Exp Ther; 1974 Sep; 190(3):492-500. PubMed ID: 4607113
    [No Abstract]   [Full Text] [Related]  

  • 42. Lysergic acid diethylamide, chlorpromazine and maze performance.
    Uyeno ET
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):389-94. PubMed ID: 5453237
    [No Abstract]   [Full Text] [Related]  

  • 43. Serotonin-sensitive adenylate cyclase activity of immature rat brain.
    von Hungen K; Roberts S; Hill DF
    Brain Res; 1975 Feb; 84(2):257-67. PubMed ID: 1078637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Some clinical and social aspects of lysergic acid diethylamide. I.
    Sarwer-Foner GJ
    Psychosomatics; 1972; 13(3):165-9 contd. PubMed ID: 4605125
    [No Abstract]   [Full Text] [Related]  

  • 45. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
    Smythies JR; Beaton J; Benington F; Morin RD
    Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
    Dyer DC
    J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
    [No Abstract]   [Full Text] [Related]  

  • 47. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
    Wallach MB; Friedman E; Gershon S
    J Pharmacol Exp Ther; 1972 Jul; 182(1):145-54. PubMed ID: 4261221
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of LSD on open field performance in rats.
    Dandiya PC; Gupta BD; Gupta ML; Patni SK
    Psychopharmacologia; 1969; 15(4):333-40. PubMed ID: 5352145
    [No Abstract]   [Full Text] [Related]  

  • 49. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-HT antagonists in rat hippocampus.
    Segal M
    Brain Res; 1976 Feb; 103(1):161-6. PubMed ID: 3262
    [No Abstract]   [Full Text] [Related]  

  • 51. Gross behavioural changes in monkeys following administration of LSD-25, and development of tolerance to LSD-25.
    Jonas S; Downer Jde C
    Psychopharmacologia; 1964 Oct; 6(4):303-6. PubMed ID: 4953438
    [No Abstract]   [Full Text] [Related]  

  • 52. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 54. On the specificity of a cat behavior model for the study of hallucinogens.
    Marini JL; Sheard MH
    Eur J Pharmacol; 1981 Apr; 70(4):479-87. PubMed ID: 7238573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lysergic acid diethylamide: dissociation of its behavioral and hyperthermic actions by DL-alpha-methyl-p-tyrosine.
    Horita A; Hamilton AE
    Science; 1969 Apr; 164(3875):78-9. PubMed ID: 5773714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.
    Buckholtz NS; Freedman DX; Middaugh LD
    Eur J Pharmacol; 1985 Mar; 109(3):421-5. PubMed ID: 3987809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of LSD on time-based schedules of reinforcement.
    Appel JB
    Psychopharmacologia; 1971; 21(2):174-86. PubMed ID: 5570198
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-lasting alterations in behavior and brain neurochemistry following continuous low-level LSD administration.
    King W; Ellison G
    Pharmacol Biochem Behav; 1989 May; 33(1):69-73. PubMed ID: 2780790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 'Candyflipping': synergistic discriminative effect of LSD and MDMA.
    Schechter MD
    Eur J Pharmacol; 1998 Jan; 341(2-3):131-4. PubMed ID: 9543229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.